Transactions
6
Insider / ABBOTT LABORATORIES
Ford Robert B
CHAIRMAN AND CEO at ABBOTT LABORATORIES · ABT
Ford Robert B, CHAIRMAN AND CEO at ABBOTT LABORATORIES, has disclosed 6 transactions in ABT since August 27, 2026: 0 purchases (0 open-market buys) and 2 sales, worth about $67.8M at the reported prices. The latest was filed August 27, 2026, 2 days after the trade.
Open-market buys
0
Sales
2
Avg. disclosure lag
2.0d
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source |
|---|---|---|---|---|---|---|---|---|---|
| ABT | Option / conversion M | August 25, 2026 | August 27, 2026 | 2d | 246,963 | — | — | derivative | Form 4 ↗ |
| ABT | Option / conversion M | August 25, 2026 | August 27, 2026 | 2d | 151,869 | — | — | derivative | Form 4 ↗ |
| ABT | Sell S | August 25, 2026 | August 27, 2026 | 2d | 180,297 | $116 | $20.9M | Form 4 ↗ | |
| ABT | Sell S | August 25, 2026 | August 27, 2026 | 2d | 218,535 | $116 | $25.3M | Form 4 ↗ | |
| ABT | Option / conversion M | August 25, 2026 | August 27, 2026 | 2d | 246,963 | $60 | $14.8M | Form 4 ↗ | |
| ABT | Option / conversion M | August 25, 2026 | August 27, 2026 | 2d | 151,869 | $44 | $6.7M | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| August 27, 2026 | Form 4 | 0001612571-26-000011 | 6 | published | EDGAR ↗ |
Sources and method
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.